Worried about your symptoms?
Start the Diabetes Insipidus test with our free AI Symptom Checker.
This will help us personalize your assessment.
By starting the symptom checker, you agree to the Privacy Policy and Terms of Use
Frequent nighttime urination
Urine urgency
Frequent urination
Fatigued
My mouth is dry
Peeing at night
Pee frequently
Not seeing your symptoms? No worries!
A disorder in which the body cannot properly regulate water levels. The cause is damage to either the kidneys or the pituitary gland in the brain.
Your doctor may ask these questions to check for this disease:
Treatment for this condition depends on the cause. The specialist may prescribe medications or hormones to help regulate water levels. Additionally, patients will be asked to monitor and adjust their intake of water and salts.
Reviewed By:
Unnati Patel, MD, MSc (Family Medicine)
Dr.Patel serves as Center Medical Director and a Primary Care Physician at Oak Street Health in Arizona. She graduated from the Zhejiang University School of Medicine prior to working in clinical research focused on preventive medicine at the University of Illinois and the University of Nevada. Dr. Patel earned her MSc in Global Health from Georgetown University, during which she worked with the WHO in Sierra Leone and Save the Children in Washington, D.C. She went on to complete her Family Medicine residency in Chicago at Norwegian American Hospital before completing a fellowship in Leadership in Value-based Care in conjunction with the Northwestern University Kellogg School of Management, where she earned her MBA. Dr. Patel’s interests include health tech and teaching medical students and she currently serves as Clinical Associate Professor at the University of Arizona School of Medicine.
Hidetaka Hamasaki, MD (Endocrinology)
Dr. Hamasaki graduated from the Hiroshima University School of Medicine and the Graduate School of Medicine, Jichi Medical University. He completed his residency at the Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Hospital and the Department of Internal Medicine, Kohnodai Hospital, National Center for Global Health and Medicine. He has served in the National Center for Global Health and Medicine Hospital and Kohnodai Hospital and joined Hamasaki Clinic in April 2017. Dr. Hamasaki specializes in diabetes and treats a wide range of internal medicine and endocrine disorders.
Content updated on Mar 31, 2024
Following the Medical Content Editorial Policy
Was this page helpful?
We would love to help them too.
With a free 3-min Diabetes Insipidus quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms

Our AI

Your report

Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
See full list
Q.
Five important things people get wrong about farxiga
A.
Farxiga is not just a sugar pill: it protects the heart and kidneys, is used for heart failure and chronic kidney disease even without diabetes, and overall preserves kidney function despite a small early reversible GFR dip. Concerns about severe dehydration or low blood pressure are usually manageable with hydration and medication adjustments. Mild to moderate liver disease is not an automatic no, though advanced cirrhosis needs caution and close monitoring. There are several important details that may affect your next steps, so see the complete answer below.
References:
Neal B, Perkovic V, Mahaffey KW, et al. (2019). Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med, 30880345.
https://pubmed.ncbi.nlm.nih.gov/30880345/
McMurray JJV, Solomon SD, Inzucchi SE, et al. (2019). Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med, 31517828.
https://pubmed.ncbi.nlm.nih.gov/31517828/
D’Amico G, Garcia-Tsao G, Pagliaro L. (2006). Natural history and prognostic indicators of survival in patients with cirrhosis: a systematic… Journal of Hepatology, 16753503.
Q.
Life past 65: What drugs should not be taken with farxiga?
A.
Key drugs to avoid or use cautiously with Farxiga after 65 include diuretics, blood pressure medicines such as ACE inhibitors, ARBs and nitrates, insulin or sulfonylureas, common NSAIDs, lithium, and potent CYP3A4 inducers or inhibitors, since combinations can raise risks of dehydration, low blood pressure, kidney problems and hypoglycemia. There are several factors to consider, including liver disease and age-related changes that may require dose adjustments, monitoring and hydration strategies; see the complete guidance below and talk with your clinician or pharmacist before changing any medication.
References:
Burness CB, & McCormack PL. (2012). Dapagliflozin: first global approval. Drugs, 22389636.
https://pubmed.ncbi.nlm.nih.gov/22389636/
D’Amico G, Garcia-Tsao G, & Pagliaro L. (2006). Natural history and prognostic indicators of survival in cirrhosis: a systematic… Journal of Hepatology, 16446105.
https://pubmed.ncbi.nlm.nih.gov/16446105/
European Association for the Study of the Liver. (2018). EASL clinical practice guidelines for the management of decompensated… Journal of Hepatology, 30089102.
Q.
What is farxiga used for?
A.
Farxiga is an SGLT2 inhibitor used to lower blood sugar in adults with type 2 diabetes, and it also helps treat heart failure with reduced ejection fraction and slow chronic kidney disease progression, even in people without diabetes. There are several factors to consider, including common side effects like genital yeast and urinary infections, dehydration and low blood pressure, and rare ketoacidosis, plus who should avoid it such as those with type 1 diabetes or severe kidney impairment; see the complete details below to guide safe use and discuss next steps with your healthcare provider.
References:
McMurray JJV, & Solomon SD. (2019). Dapagliflozin in patients with heart failure and reduced ejecti… Lancet, 31606405.
https://pubmed.ncbi.nlm.nih.gov/31606405/
Heerspink HJL, & Correa-Rotter R. (2020). Dapagliflozin in patients with chronic kidney disease… N Engl J Med, 32353293.
https://pubmed.ncbi.nlm.nih.gov/32353293/
Foucher J, & de Lédinghen V. (2006). Diagnosis of cirrhosis by transient elastography: a prospect… Gastroenterology, 16530523.
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.

“World’s Best Digital
Health Companies”
Newsweek 2024

“Best With AI”
Google Play Best of 2023

“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)

Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1Dabrowski E, Kadakia R, Zimmerman D. Diabetes insipidus in infants and children. Best Pract Res Clin Endocrinol Metab. 2016 Mar;30(2):317-28. doi: 10.1016/j.beem.2016.02.006. Epub 2016 Feb 27. PMID: 27156767.
https://www.sciencedirect.com/science/article/abs/pii/S1521690X16000117?via%3DihubDi Iorgi N, Napoli F, Allegri AE, Olivieri I, Bertelli E, Gallizia A, Rossi A, Maghnie M. Diabetes insipidus--diagnosis and management. Horm Res Paediatr. 2012;77(2):69-84. doi: 10.1159/000336333. Epub 2012 Mar 16. PMID: 22433947.
https://www.karger.com/Article/FullText/336333Robertson GL. Diabetes insipidus: Differential diagnosis and management. Best Pract Res Clin Endocrinol Metab. 2016 Mar;30(2):205-18. doi: 10.1016/j.beem.2016.02.007. Epub 2016 Feb 18. PMID: 27156759.
https://www.sciencedirect.com/science/article/abs/pii/S1521690X16000129?via%3DihubSchernthaner-Reiter MH, Stratakis CA, Luger A. Genetics of Diabetes Insipidus. Endocrinol Metab Clin North Am. 2017 Jun;46(2):305-334. doi: 10.1016/j.ecl.2017.01.002. Epub 2017 Feb 28. PMID: 28476225.
https://www.sciencedirect.com/science/article/abs/pii/S0889852917300026?via%3Dihub